Abstract: REVIEW
ARTICLE
e-ISSN: 2717-7904
https://doi.org/10.37662/jpt.2022.999481
Evaluation the plausibility of repurpose of levamisole
and niclosamide in treatment of Covid-19
Ahmed Badri Abed1* , Safiye Elif Korcan2
Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Uşak University, Uşak, Turkey
Uşak Health Training School, Uşak University, Uşak, Turkey
1
2
ARTICLE INFO
ABSTRACT
Article history:
Since the world health organization declared the pandemic of covid 19,
many drugs have been tested and re-evaluated to find effective treatment
for the novel corona virus infection. Niclosamide and Levamisole which are
FDA approved anthelmintic drugs have been evaluated by many researchers
and agencies to repurpose of these drugs as additional options for existing
treatment strategy used for patients with Covid-19. Hence we are trying in this
review to introduce most reports that evaluated the use of Niclosamide and
Levamisole for treatment of patients infected with Covid 19. We concluded
that the encouraging studies regarding the repurpose of the two drugs may
highlighting for further studies that can widening the options for existing
treatment strategy used for patients with COVID-19.
Received
Revised
Accepted
Online
Published
22 Sep 2021
26 Jan 2022
24 Oct 2022
04 Nov 2022
04 Nov 2022
Keywords:
Anthelmintic drugs
Covid-19
Levamisole
Niclosamide
SARS-CoV-2
*Corresponding author:
ahmbiq8@gmail.com
This is an open-access article licensed under the Creative Commons Attribution 4.0 International License (CC-BY).
{ 'indexed': {'date-parts': [[2022, 11, 8]], 'date-time': '2022-11-08T05:54:19Z', 'timestamp': 1667886859297},
'reference-count': 0,
'publisher': 'Journal of Pharmaceutical Technology published by Mustafa Sinan Kaynak',
'content-domain': {'domain': [], 'crossmark-restriction': False},
'accepted': {'date-parts': [[2022, 12, 1]]},
'abstract': '<jats:p xml:lang="tr">Since the world health organization declared the pandemic of covid 19, '
'many drugs have been tested and re-evaluated to find effective treatment for the novel corona '
'virus infection. Niclosamide and Levamisole which are FDA approved anthelmintic drugs have '
'been evaluated by many researchers and agencies to repurpose of these drugs as additional '
'options for existing treatment strategy used for patients with Covid-19. Hence we are trying '
'in this review to introduce most reports that evaluated the use of Niclosamide and Levamisole '
'for treatment of patients infected with Covid 19. We concluded that the encouraging studies '
'regarding the repurpose of the two drugs may highlighting for further studies that can '
'widening the options for existing treatment strategy used for patients with '
'COVID-19.</jats:p>',
'DOI': '10.37662/jpt.2022.999481',
'type': 'journal-article',
'created': {'date-parts': [[2022, 11, 7]], 'date-time': '2022-11-07T14:59:52Z', 'timestamp': 1667833192000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Evaluation the plausibility of repurpose of levamisole and niclosamide in treatment of covid-19',
'prefix': '10.37662',
'author': [ { 'ORCID': 'http://orcid.org/0000-0002-7803-7917',
'authenticated-orcid': True,
'given': 'Ahmed Bedri',
'family': 'Abed',
'sequence': 'first',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0001-7875-5516',
'authenticated-orcid': True,
'given': 'Safiye Elif',
'family': 'Korcan',
'sequence': 'additional',
'affiliation': []}],
'member': '24579',
'published-online': {'date-parts': [[2022, 12, 1]]},
'container-title': 'Journal of Pharmaceutical Technolgy',
'original-title': [],
'language': 'en',
'deposited': { 'date-parts': [[2022, 11, 7]],
'date-time': '2022-11-07T14:59:55Z',
'timestamp': 1667833195000},
'score': 1,
'resource': {'primary': {'URL': 'https://dergipark.org.tr/en/pub/jpharmtech/issue/73354/999481'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 12, 1]]},
'references-count': 0,
'URL': 'http://dx.doi.org/10.37662/jpt.2022.999481',
'relation': {},
'ISSN': ['2717-7904'],
'subject': [],
'container-title-short': 'jpt',
'published': {'date-parts': [[2022, 12, 1]]}}
